| Kent B Remley, MD | |
|
1665 Highway 34 E, Suite 100, Newnan, GA 30265-2404 | |
| (770) 252-7557 | |
| (770) 252-7513 |
| Full Name | Kent B Remley |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 42 Years |
| Location | 1665 Highway 34 E, Newnan, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114994605 | NPI | - | NPPES |
| 200076860 | Medicaid | IN |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| M And B Imaging, Pc | 1557623782 | 56 |
| Pro Radiology, Llc | 1052696432 | 68 |
| Synergy Radiology Llc | 2668727744 | 66 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
| Entity Name | Pro Radiology, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164966461 PECOS PAC ID: 1052696432 Enrollment ID: O20170327002470 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
| Entity Name | Allegiance Imaging And Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902346422 PECOS PAC ID: 3577838689 Enrollment ID: O20170928003723 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
| Entity Name | M & B Imaging, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932624723 PECOS PAC ID: 1557623782 Enrollment ID: O20180327002648 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
| Entity Name | Synergy Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558886341 PECOS PAC ID: 2668727744 Enrollment ID: O20180613001114 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kent B Remley, MD 1665 Highway 34 E, Suite 100, Newnan, GA 30265-2404 Ph: (317) 815-7021 | Kent B Remley, MD 1665 Highway 34 E, Suite 100, Newnan, GA 30265-2404 Ph: (770) 252-7557 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the continued uptake of marketed and emerging interleukin and TNF-alpha inhibitors and a twofold increase in the penetration of biologics in the moderate-to-severe population will drive the psoriasis drug market to double from $3.4 billion in 2009 to $6.8 billion in 2019 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
"The Canadian Heart Health Strategy and Action Plan is the prescription that Canada urgently needs to ensure that Canadians get timely and efficient patient-centred services and access to care when they need it," says Dr. Charles R. Kerr, President of the Canadian Cardiovascular Society.
Roche announced today that after priority review, Health Canada has approved HERCEPTIN(R) (trastuzumab), in combination with XELODA(R) (capecitabine) or intravenous 5-fluorouracil and cisplatin, for the first-line treatment of patients with HER2-positive metastatic adenocarcinoma of the stomach (gastric cancer) or gastro-esophageal cancer.
Artificial intelligence applications in the fields of informatics, machine learning and personalized medicine have been revolutionizing medicine and radiology. For example, we already use image interpretation to detect breast cancer in its earliest stages.
Pain was the main driver of seeking medical care in an Arthritis Care & Research study of patients with osteoarthritis. In addition to pain, insomnia and depression increased health care use.
› Verified 9 days ago
Dr. Nathan J Neufeld, D.O. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Celebrate Life Pkwy, Newnan, GA 30265 Phone: 770-400-7007 | |
Dr. Brian Stephenson Zeh, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 775 Poplar Rd, Suite 200, Newnan, GA 30265 Phone: 404-351-7654 Fax: 404-609-7605 |